NR: No Reference; SC: Subcutaneous; Symptom Severity: 1=mild,
2=moderate, 3=severe
¥ In the Okubo 2020 trial all patients received concomitant
antihistamines and nasal corticosteroids as standard of care treatment
*Standard of care treatment + placebo
|